{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:29:24Z","timestamp":1782484164814,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijcard.2020.10.034","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T19:28:34Z","timestamp":1602962914000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis"],"prefix":"10.1016","volume":"325","author":[{"given":"Tingjie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizhen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Michael","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronglih","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.10.034_bb0005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0010","doi-asserted-by":"crossref","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet (London, England). 2016;387:2641\u201326542016;387:2641\u201354.","DOI":"10.1016\/S0140-6736(15)01274-X"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2018-10-882159","article-title":"AL amyloidosis cardiac staging updated using BNP","volume":"133","author":"Venner","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0020","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0025","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/13506129.2019.1646639","article-title":"Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study","volume":"26","author":"Bartier","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1006\/bbrc.1996.5997","article-title":"Oxidative stress is found in amyloid deposits in systemic amyloidosis","volume":"232","author":"Ando","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2009.04.044","article-title":"Systemic and microvascular oxidative stress induced by light chain amyloidosis","volume":"145","author":"Migrino","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ejhf.1039","article-title":"Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis","volume":"20","author":"Siegismund","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjms.2016.06.014","article-title":"High-density lipoprotein and inflammation and its significance to atherosclerosis","volume":"352","author":"Hu","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0003319713512173","article-title":"Low high-density lipoprotein cholesterol is characterized by elevated oxidative stress","volume":"65","author":"Karabacak","year":"2014","journal-title":"Angiology."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCRESAHA.111.258673","article-title":"Novel biological functions of high-density lipoprotein cholesterol","volume":"111","author":"Mineo","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0070","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","article-title":"Relations of lipid concentrations to heart failure incidence: the Framingham heart study","volume":"120","author":"Velagaleti","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13506129.2019.1578742","article-title":"Regional amyloid distribution and impact on mortality in light-chain amyloidosis: a T1 mapping cardiac magnetic resonance study","volume":"26","author":"Wan","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","article-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2014","volume":"20","author":"Nishi","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0090","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0095","first-page":"1","volume":"15","year":"2018","journal-title":"J. Geriatric Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1523-1755.1999.00585.x","article-title":"Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome","volume":"56","author":"Liang","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0105","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/ndt\/gfr136","article-title":"Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor","volume":"26","author":"Vaziri","year":"2011","journal-title":"Nephrol. Dialysis Transplant."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2016.04.035","article-title":"Brokbals E, Aus dem Siepen F, Bauer R, Hein S, Aurich M, et al. cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis","volume":"68","author":"Kristen","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137716","article-title":"Light chain amyloid fibrils cause metabolic dysfunction in human Cardiomyocytes","volume":"10","author":"McWilliams-Koeppen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0120","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.26444\/aaem\/92350","article-title":"High-density lipoprotein (HDL) cholesterol - more complicated than we think?","volume":"25","author":"Nessler","year":"2018","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0140","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0145","doi-asserted-by":"crossref","unstructured":"Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress. Clin. Sci. (London, England : 1979). 2009;116:87\u2013982009;116:87\u201398.","DOI":"10.1042\/CS20080106"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0155","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.2174\/1381612820666140622200916","article-title":"Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) bound to LDL and HDL","volume":"20","author":"Tellis","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0160","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1053\/euhj.1998.1188","article-title":"Uric acid in chronic heart failure: a marker of chronic inflammation","volume":"19","author":"Leyva","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10557-017-6752-z","article-title":"Immunity, inflammation, and oxidative stress in heart failure: emerging molecular targets","volume":"31","author":"Ayoub","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2020.10.034_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13506129.2019.1698417","article-title":"Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype","volume":"27","author":"Driggin","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.ijcard.2020.10.034_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","article-title":"What is new in diagnosis and management of light chain amyloidosis?","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320339875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320339875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:49:55Z","timestamp":1759092595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320339875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":35,"alternative-id":["S0167527320339875"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.10.034","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}